心臓血管麻酔Positive and Negativeリスト25

出版社： 中外医学社
著者：
発行日： 2020-09-25
分野： 臨床医学：外科  >  麻酔科学/ペイン
ISBN： 9784498055469
電子書籍版： 2020-09-25 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

3,520 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,520 円(税込)

購入する

商品紹介

日々の麻酔管理を「エビデンスに基づく」と自信を持って言えますか？
実臨床で幅広く⾏われている⼼臓⾎管⿇酔管理の中で，意⾒が分かれている項⽬についてエビデンスがある程度確⽴しており実際の臨床現場で有⽤であると考えられるʼPositive listʼ，エビデンスがない，あるいは不⼗分であるʼNegative listʼと解説ですぐに臨床に活⽤できる読みやすい内容．現場で迷ったときに読んでいてよかったと思う1冊．

目次

  • 循環作動薬
    　1．強心薬：ドパミン，ドブタミン，PDEIII阻害薬の使用の是非について
    　2．血管収縮薬：人工心肺後のvasoplegic shockに対する適切な血管収縮薬は何か？
    　3．硝酸薬とニコランジル
    　4．βブロッカー

    麻酔管理
    　5．心臓血管麻酔導入時の鎮静薬
    　6．術中鎮痛：フェンタニルorレミフェンタニル？
    　7．吸入麻酔薬の心保護作用
    　8．デクスメデトミジン
    　9．トラネキサム酸
    　10．区域麻酔と心臓血管麻酔

    モニタリング
    　11．肺動脈カテーテル
    　12．低侵襲血行動態モニタリング
    　13．経食道心エコー使用のエビデンス
    　14．血液凝固モニタリング
    　15．局所脳酸素飽和度（rSO2）の活用
    　16．人工心肺中の血行動態
    　17．MEPモニタリング
    　18．スパイナルドレナージ

    術中管理
    　19．心臓血管麻酔における輸液療法：GDTは心臓血管麻酔でも有効か？
    　20．心臓血管麻酔における輸血療法

    術後管理
    　21．心臓血管手術後の呼吸管理
    　22．心臓血管手術後の循環管理

    エキスパートオピニオン 私ならこうする心臓血管管理
    　23．Stanford A型急性大動脈解離手術の麻酔導入：導入法とモニタリング
    　24．予期しない人工心肺後の低血圧，低心拍出症候群への対応
    　25．輸血拒否患者（エホバの証人）での循環管理法

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

循環作動薬

P.5 掲載の参考文献
1) Lomivorotov VV, Efremov SM, Pokushalov EA, et al. Randomized trial of fish oil infusion to prevent atrial fibrillation after cardiac surgery : data from an implantable continuous cardiac monitor. J Cardiothorac Vasc Anesth. 2014 ; 28 : 1278-84.
PubMed
2) Chen JC, Kaul P, Levy JH, et al. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med. 2007 ; 35 : 1296-301.
PubMed
3) Maganti MD, Rao V, Borger MA, et al. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation. 2005 ; 112 : I448-52.
PubMed
4) Maganti M, Badiwala M, Sheikh A, et al. Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg. 2010 ; 140 : 790-6.
PubMed
5) Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery : trends over 20 years. Ann Thorac Surg. 2011 ; 92 : 1678-84.
PubMed
6) Overgaard CB, Dzavik V. Inotropes and vasopressors : review of physiology and clinical use in cardiovascular disease. Circulation. 2008 ; 118 : 1047-56.
PubMed
7) Bayram M, De Luca L, Massie MB, et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol. 2005 ; 96 : 47G-58G.
PubMed
8) MacGregor DA, Smith TE, Prielipp RC, et al. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology. 2000 ; 92 : 338-46.
PubMed
9) van de Borne P, Oren R, Somers VK. Dopamine depresses minute ventilation in patients with heart failure. Circulation. 1998 ; 98 : 126-31.
PubMed
10) Nishida O, Ogura H, Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). J Intensive Care. 2018 ; 6. Article number : 7.
 
11) Kellum JA, Decker JM. Use of dopamine in acute renal failure : a meta-analysis. Crit Care Med. 2001 ; 29 : 1526-31.
 
12) Ruffolo RR Jr. The pharmacology of dobutamine. Am J Med Sci. 1987 ; 294 : 244-8.
PubMed
13) Barbato E, Bartunek J, Wyffels E, et al. Effects of intravenous dobutamine on coronary vasomotion in humans. J Am Coll Cardiol. 2003 ; 42 : 1596-601.
PubMed
14) Fleming GA, Murray KT, Yu C, et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation. 2008 ; 118 : 1619-25.
PubMed
15) Zangrillo A, Biondi-Zoccai G, Ponschab M, et al. Milrinone and mortality in adult cardiac surgery : a meta-analysis. J Cardiothorac Vasc Anesth. 2012 ; 26 : 70-7.
PubMed
16) Majure DT, Greco T, Greco M, et al. Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery : an update. J Cardiothorac Vasc Anesth. 2013 ; 27 : 220-9.
PubMed
17) Ushio M, Egi M, Wakabayashi J, et al. Impact of milrinone administration in adult cardiac surgery patients : updated meta-analysis. J Cardiothorac Vasc Anesth. 2016 ; 30 : 1454-60.
PubMed
18) Greco T, Calabro MG, Covello RD, et al. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth. 2015 ; 114 : 746-56.
PubMed
P.14 掲載の参考文献
1) 菅弘之, 高木都, 後藤葉一, 他. 心室・動脈カップリング. In : 日本生体医工学会, 編. 心臓力学とエナジェティクス. コロナ社 : 2000. p.110-26.
 
2) Spiegel R. Stressed vs. unstressed volume and its relevance to critical care practitioners. Clin Exp Emerg Med. 2016 ; 3 : 52-4.
PubMed
3) Kalmar AF, Allaert S, Pletinckx P, et al. Phenylephrine increases cardiac output by raising cardiac preload in patients with anesthesia induced hypotension. J Clin Monit Comput. 2018 ; 32 : 969-76.
PubMed
4) Rebet O, Andremont O, Gerard JL, et al. Preload dependency determines the effects of phenylephrine on cardiac output in anaesthetised patients : a prospective observational study. Eur J Anaesthesiol. 2016 ; 33 : 638-44.
PubMed
5) Monnet X, Jabot J, Maizel J, et al. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med. 2011 ; 39 : 689-94.
PubMed
6) 砂川賢二. Guytonの静脈還流は医学部で教えるべきである (総説). 循環制御. 2016 ; 37 : 168-77.
 
7) Overgaard CB, Dzavik V. Inotropes and vasopressors : review of physiology and clinical use in cardiovascular disease. Circulation. 2008 ; 118 : 1047-56.
PubMed
8) Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care. 2011 ; 1 : 1.
PubMed
9) Hamzaoui O, Georger JF, Monnet X, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010 ; 14 : R142.
PubMed
10) Singer M. Catecholamine treatment for shock--equally good or bad? Lancet. 2007 ; 370 : 636-7.
PubMed
11) Gamper G, Havel C, Arrich J, et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev. 2016 ; 2 (2) : CD003709.
PubMed
12) Moller MH, Claudius C, Junttila E, et al. Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure. Acta Anaesthesiol Scand. 2016 ; 60 : 1347-66.
PubMed
13) Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign : International guidelines for management of sepsis and septic shock : 2016. Crit Care Med. 2017 ; 45 : 486-552.
PubMed
14) Avni T, Lador A, Lev S, et al. Vasopressors for the treatment of septic shock : systematic review and meta-analysis. PLoS One. 2015 ; 10 : e0129305.
PubMed
15) Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008 ; 34 : 2226-34.
PubMed
16) Malay MB, Ashton JL, Dahl K, et al. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med. 2004 ; 32 : 1327-31.
PubMed
17) Shaefi S, Mittel A, Klick J, et al. Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth. 2018 ; 32 : 1013-22.
PubMed
18) Liu H, Yu L, Yang L, et al. Vasoplegic syndrome : an update on perioperative considerations. J Clin Anesth. 2017 ; 40 : 63-71.
 
19) Orozco Vinasco DM, Triana Schoonewolff CA, Orozco Vinasco AC. Vasoplegic syndrome in cardiac surgery : definitions, pathophysiology, diagnostic approach and management. Rev Esp Anestesiol Reanim. 2019 ; 66 : 277-87.
PubMed
20) 澤村成史. 病態から見る血圧 血管麻痺症候群 (vasoplegic syndrome). In : 坪川恒久, 他. LiSA 別冊 血圧. メディカル・サイエンス・インターナショナル ; 2019. p.139-44.
 
21) Lambden S, Creagh-Brown BC, Hunt J, et al. Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018 ; 22 : 174.
 
22) Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery : the VANCS randomized controlled trial. Anesthesiology. 2017 ; 126 : 85-93.
PubMed
23) Currigan DA, Hughes RJ, Wright CE, et al. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries : an in vitro study. Anesthesiology. 2014 ; 121 : 930-6.
 
P.25 掲載の参考文献
1) Munzel T, Daiber A, Gori T. Nitrate therapy : new aspects concerning molecular action and tolerance. Circulation. 2011 ; 123 : 2132-44.
PubMed
2) Tarkin JM, Kaski JC. Vasodilator therapy : nitrates and nicorandil. Cardiovasc Drugs Ther. 2016 ; 30 : 367-78.
PubMed
3) Murad F. The excitement and rewards of research with our discovery of some of the biological effects of nitric oxide. Circ Res. 2003 ; 92 : 339-41.
PubMed
4) Kleschyov AL, Oelze M, Daiber A, et al. Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res. 2003 ; 93 : e104-12.
PubMed
5) Nunez C, Victor VM, Tur R, et al. Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO. Circ Res. 2005 ; 97 : 1063-9.
PubMed
6) Tarkin JM, Kaski JC. Nicorandil and long-acting nitrates : vasodilator therapies for the management of chronic stable angina pectoris. European Cardiology. 2018 ; 13 : 23-8.
PubMed
7) Feldman RL, Pepine CJ, Conti CR. Magnitude of dilatation of large and small coronary arteries of nitroglycerin. Circulation. 1981 ; 64 : 324-33.
PubMed
8) Russo G, Di Franco A, Lamendola P, et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther. 2013 ; 27 : 229-34.
PubMed
9) Mackenzie IS, Maki-Petaja KM, McEniery CM, et al. Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler Thromb Vasc Biol. 2005 ; 25 : 1891-5.
 
10) Elkayam U, Kulick D, McIntosh N, et al. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation. 1987 ; 76 : 577-84.
PubMed
11) Cintron GB, Glasser SP, Weston BA, et al. Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction. Am J Cardiol. 1988 ; 61 : 21-5.
PubMed
12) 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2014年改訂版). 2014. https://www.j-circ.or.jp/old/guideline/pdf/JCS2014_kyo_h.pdf (2020年7月16日閲覧)
 
13) Zhao N, Xu J, Singh B, et al. Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2016 ; (8) : CD010726.
PubMed
14) The ESPRIM trial : short-term treatment of acute myocardial infarction with molsidomine. European Study of Prevention of Infarct with Molsidomine (ESPRIM) Group. Lancet. 1994 ; 344 : 91-7.
PubMed
15) GISSI-3 : effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet. 1994 ; 343 : 1115-22.
PubMed
16) ISIS-4 : a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995 ; 345 : 669-85.
 
17) Kohro T, Hayashi D, Okada Y, et al. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J. 2007 ; 71 : 1835-40.
PubMed
18) Yamauchi T, Hagiwara N, Kasanuki H, et al. Long-term nitrate use in acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology nitrate evaluation program). Cardiovasc Drugs Ther. 2008 ; 22 : 177-84.
PubMed
19) Kojima S, Matsui K, Sakamoto T, et al. Long-term nitrate therapy after acute myocardial infarction does not improve or aggravate prognosis. Circ J. 2007 ; 71 : 301-7.
PubMed
20) Ambrosio G, Del Pinto M, Tritto I, et al. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes : insights from 52,693 patients in the Global Registry of Acute Coronary Events. Eur Heart J. 2010 ; 31 : 430-8.
PubMed
21) 急性冠症候群ガイドライン (2018年改訂版). 2019. https://www.j-circ.or.jp/old/guideline/pdf/JCS2018_kimura.pdf (2020年7月16日閲覧)
 
22) Tsujimoto T, Kajio H. Use of nitrates and risk of cardiovascular events in patients with heart failure with preserved ejection fraction. Mayo Clin Proc. 2019 ; 94 : 1210-20.
PubMed
23) Redfield MM, Anstrom KJ, Levine JA, et al. Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med. 2015 ; 373 : 2314-24.
PubMed
24) Kuno A, Critz SD, Cohen MV, et al. Nicorandil opens mitochondrial K (ATP) channels not only directly but also through a NO-PKG-dependent pathway. Basic Res Cardiol. 2007 ; 102 : 73-9.
 
25) Suryapranata H, MacLeod D. Nicorandil and cardiovascular performance in patients with coronary artery disease. J Cardiovasc Pharmacol. 1992 ; 20 Suppl 3 : S45-51.
 
26) Matsubara T, Minatoguchi S, Matsuo H, et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol. 2000 ; 35 : 345-51.
 
27) 原哲也, 澄川耕二. 周術期の心筋保護対策 薬理学的プレコンディショニングを中心に. 日本臨床麻酔学会誌. 2009 ; 29 : 189-98.
Medical*Online
28) 木下浩之. 長期予後を考えた周術期管理とは? 周術期虚血性心疾患とニコランジル. 日本臨床麻酔学会誌. 2014 ; 34 : 392-6.
 
29) Kaneko T, Saito Y, Hikawa Y, et al. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery. Br J Anaesth. 2001 ; 86 : 332-7.
PubMed
30) Kashimoto S, Seki M, Ishiguro T, et al. Nicorandil decreases cardiac events during and after noncardiac surgery. J Clin Anesth. 2007 ; 19 : 44-8.
 
31) 金子高穂, 林田道子, 斎藤裕, 他. 虚血性心疾患危険因子を有する患者の開腹術におけるニコランジルの術中心筋虚血予防効果. 麻酔. 2000 ; 49 : 54-9.
Medical*Online
32) Saha KK, Kumar A, Deval MM, et al. Nicorandil infusion during off-pump coronary artery bypass grafting reduces incidence of intra-aortic balloon pump insertion. Innovations (Phila). 2016 ; 11 : 123-7.
PubMed
33) Hayashi Y, Sawa Y, Ohtake S, et al. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass. J Cardiovasc Pharmacol. 2001 ; 38 : 21-8.
PubMed
34) Ito I, Hayashi Y, Kawai Y, et al. Prophylactic effect of intravenous nicorandil on perioperative myocardial damage in patients undergoing off-pump coronary artery bypass surgery. J Cardiovasc Pharmacol. 2004 ; 44 : 501-6.
PubMed
35) Yamamoto S, Yamada T, Kotake Y, et al. Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2008 ; 22 : 548-53.
PubMed
P.33 掲載の参考文献
1) Viljoen JF, Estafanous FG, Kellner GA. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg. 1972 ; 64 : 826-30.
PubMed
2) Miller RR, Olson HG, Amsterdam EA, et al. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 ; 293 : 416-8.
PubMed
3) Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of perioperative ischemia research group. N Engl J Med. 1996 ; 335 : 1713-20.
 
4) Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999 ; 341 : 1789-94.
 
5) Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005 ; 353 : 349-61.
PubMed
6) POISE Study Group ; Devereaux PJ, Yang H, Yusuf S, et al. Effects of extendedrelease metoprolol succinate in patients undergoing non-cardiac surgery (POISE Trial) : a randomised controlled trial. Lancet. 2008 ; 371 : 1839-47.
 
7) Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : a report of the American College of Cardiology foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 ; 120 : e169-276.
 
8) Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative β-blockade and postoperative mortality. Anesthesiology. 2010 ; 113 : 794-805.
 
9) London MJ, Hur K, Schwartz GG, et al. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013 ; 309 : 1704-13.
 
10) Flu WJ, van Kuijk JP, Chonchol M, et al. Timing of pre-operative betablocker treatment in vascular surgery patients : influence on post-operative outcome. J Am Coll Cardiol. 2010 ; 56 : 1922-9.
PubMed
11) Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2014 ; 130 : e278-333.
PubMed
12) Beattie WS, Wijeysundera DN, Karkouti K, et al. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg. 2008 ; 106 : 1039-48.
PubMed
13) Blessberger H, Kammler J, Domanovits H, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cocrane Database Syst Rev. 2014 ; (9) : CD004476.
 
14) Patorno E, Wang SV, Schneeweiss S, et al. Patterns of β-blocker initiation in patients undergoing intermediate to high-risk. Noncardiac Surgery Heart J. 2015 ; 170 : 812-20.
 
15) Wang L, Wang H, Hou X. Short-term effects of preoperative beta-blocker use for isolated coronary artery bypass grafting : a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2018 ; 155 : 620-9.
 
16) Schubert SA, Hawkins RB, Mehaffey JH, et al. Preoperativeβ-blocker use correlates with worse outcomes in patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2019 ; 158 : 1589-97.
 
17) 2020年改訂版不整脈薬物治療ガイドライン. 2020. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Ono.pdf (2020年7月14日閲覧)
 
18) Sigurdsson MI, Longford NT, Heydarpour M, et al. Duration of postoperative atrial fibrillation after cardiac surgery is associated with worsened longterm survival. Ann Thorac Surg. 2016 ; 102 : 2018-26.
PubMed
19) Sakamoto A, Kitakaze M, Takamoto S, et al. Landiolol, an ultra-short-acting β1-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery : prospective, multicenter, randomized, open-label study (JL-KNIGHT study). Circ J. 2012 ; 76 : 1097-101.
 
20) Andrade JG, Macle L, Nattel S, et al. Contemporary atrial fibrillation management : a comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol. 2017 ; 33 : 965-76.
PubMed
21) 急性・慢性心不全診療ガイドライン (2017年改訂版). 2018. https://www.j-circ.or.jp/old/guideline/pdf/JCS2017_tsutsui_h.pdf (2020年7月14日閲覧)
 
22) Sezai A, Minami K, Nakai T, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting : new evidence from the PASCAL trial. J Thorac Cardiovasc Surg. 2011 ; 141 : 1478-87.
 
23) Yamada M, Takahashi S, Yamashita S, et al. Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass. J Clin Anesth. 2018 ; 51:125-6.
PubMed
24) Ikeda T, Shiga T, Shimizu W, et al. Efficacy and safety of the ultra-shortacting β1-selective blocker landiolol in patients with recurrent hemodynamically unstable ventricular tachyarrhymias - outcomes of J-Land II Study. Circ J. 2019 ; 83 : 1456-62.
 
25) Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock : a randomized clinical trial. JAMA. 2013 ; 310 : 1683-91.
PubMed
26) Yamakage M, Iwasaki S, Jeong SW, et al. Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. Heart Lung. 2009 ; 38 : 48-55.
PubMed
27) Lee M, Kwon T, Kim S, et al. Comparative evaluation of the effect of remifentanil and 2 different doses of esmolol on pain during propofol injection : a double-blind, randomized clinical consort study. Medicine (Baltimore). 2017 ; 96 (10) : e6288.
 
28) Gelineau AM, King MR, Ladha KS, et al. Intraoperative esmolol as an adjunct for perioperative opioid and postoperative pain reduction : a systematic review, meta-analysis, and meta-regression. Anesth Analg. 2018 ; 126 : 1035-49.
PubMed
29) Zhou L, Li Y, Li X, et al. Propranolol attenuates surgical stress-induced elevation of the regulatory T cell response in patients undergoing radical mastectomy. J Immunol. 2016 ; 196 : 3460-9.
 

麻酔管理

P.39 掲載の参考文献
1) Hendrickx JF, Eger EI 2nd, Sonner JM, et al. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg. 2008 ; 107 : 494-506.
 
2) Myles PS, Williams DL, Hendrata M, et al. Patient satisfaction after anaesthesia and surgery : results of a prospective survey of 10,811 patients. Br J Anaesth. 2000 ; 84 : 6-10.
PubMed
3) Akavipat P, Sookplung P, Premsamran P, et al. The Thai anesthesia incident monitoring study (Thai AIMS) : an analysis of 21 awareness events. J Med Assoc Thai. 2009 ; 92 : 335-41.
PubMed
4) Xu L, Wu AS, Yue Y. The incidence intra-operative awareness during general anesthesia in China : a multi-center observational study. Acta Anaesthesiol Scand. 2009 ; 53 ; 873-82.
 
5) Wang Y, Yue Y, Sun YH, et al. Investigation and analysis of incidence of awareness in patients undergoing cardiac surgery in Beijing, China. Chin Med J (Eng). 2005 ; 118 : 1190-4.
 
6) Wang Q, Wang Z, Hao Z, et al. The occurrence of intraoperative awareness in cardiac surgery. Chinese J Anesth. 2013 ; 33 : 1407-8.
 
7) Dawson PJ, Bjorksten AR, Blake DW, et al. The effects of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam. J Cardiothorac Vasc Anesth. 1997 ; 11 : 556-61.
PubMed
8) Zheng Q, Wang Q, Wu C, et al. Is hyperlipidemia potential protective factor against intraoperative awareness in cardiac surgery? J Cardiothorac Surg. 2016 ; 11 : 60.
PubMed
9) Sigtermans M, Dahan A, Mooren R, et al. S (+) -ketamine effect on experimental pain and cardiac output : a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology. 2009 ; 111 : 892-903.
PubMed
10) Gelissen HP, Epema AH, Henning RH, et al. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology. 1996 ; 84 : 397-403.
PubMed
11) Hanouz JL, Persehaye E, Zhu L, et al. The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium : the effect of adrenoceptor blockade. Anesth Analg. 2004 ; 99 : 1689-95.
PubMed
12) Marlow R, Reich DL, Neustein S, et al. Haemodynamic response to induction of anaesthesia with ketamine/midazolam. Can J Anaesth. 1991 ; 38 : 844-8.
PubMed
13) Hudetz JA, Iqbal Z, Gandhi SD, et al. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand. 2009 ; 53 : 864-72.
PubMed
14) Lester L, Mitter N, Berkowitz DE, et al. Pharmacology of anesthetic drug. In : Kaplan JA, Augoustides JG, Manecke GR, et al, editors. Kaplan's Cardiac Anesthesia. 7th edition. Elsevier ; 2017. p.247-91.
 
P.47 掲載の参考文献
1) Myles PS, Hunt JO, Fletcher H, et al. Remifentanil, fentanyl, and cardiac surgery : a double-blinded, randomized, controlled trial of costs and outcomes. Anesth Analg. 2002 ; 95 : 805-12.
PubMed
2) Howie MB, Cheng D, Newman MF, et al. A randomized double-blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. Anesth Analg. 2001 ; 92 : 1084-93.
PubMed
3) Mollhoff T, Herregods L, Moerman A, et al. Comparative efficacy and safety of remifentanil and fentanyl in 'fast track' coronary artery bypass graft surgery : a randomized, double-blind study. Br J Anaesth. 2001 ; 87 : 718-26.
PubMed
4) Greco M, Landoni G, Biondi-Zoccai G, et al. Remifentanil in cardiac surgery : a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2012 ; 26 : 110-6.
PubMed
5) Rong LQ, Kamel MK, Rahouma M, et al. High-dose versus low-dose opioid anesthesia in adult cardiac surgery : a meta-analysis. J Clin Anesth. 2019 ; 57 : 57-62.
PubMed
6) Steinlechner B, Dworschak M, Birkenberg B, et al. Low-dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery : a dose-finding study. Br J Anaesth. 2007 ; 98 : 598-603.
PubMed
7) Ouattara A, Boccara G, Kockler U, et al. Remifentanil induces systemic arterial vasodilation in humans with a total artificial heart. Anesthesiology. 2004 ; 100 : 602-7.
PubMed
8) Duman A, Sahin SA, Atalik KE, et al. The in vitro effects of remifentanil and fentanyl on isolated human right atria and saphenous veins. J Cardiothorac Vasc Anesth. 2003 ; 17 : 465-9.
 
9) Bolliger D, Seeberger MD, Kasper J, et al. Remifentanil does not impair left ventricular systolic and diastolic function in young healthy patients. Br J Anaesth. 2011 ; 106 : 573-9.
 
10) Fujii K, Iranami H, Nakamura Y, et al. High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia. Anesth Analg. 2011 ; 112 : 1169-73.
PubMed
11) Ishii H. Cardioprotection with opioids--trusted old friends--clinical science. Curr Pharm Des. 2014 ; 20 : 5794-8.
PubMed
12) Tanaka K. Opioid induced cardioprotection. Curr Pharm Des. 2014 ; 20 : 5696-705.
PubMed
13) Headrick JP, See Hoe LE, Du Toit EF, et al. Opioid receptors and cardioprotection-- 'opioidergic conditioning' of the heart. Br J Pharmacol. 2015 ; 172 : 2026-50.
PubMed
14) He SF, Jin SY, Yang W, et al. Cardiac μ-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure. Br J Anaesth. 2018 ; 121 : 26-37.
 
15) Wong GTC, Huang Z, Ji S, et al. Remifentanil reduces the release of biochemical markers of myocardial damage after coronay artery bypass surgery : a randomized trial. J Cardiothorac Vasc Anesth. 2010 ; 24 : 790-6.
 
16) Muehlschlegel JD, Perry TE, Liu KY, et al. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J. 2009 ; 30 : 1574-83.
PubMed
17) van Gulik L, Ahlers SJ, van de Garde EM, et al. Remifentanil during cardiac surgery is associated with chronic thoracic pain 1 year after sternotomy. Br J Anaesth. 2012 ; 109 : 616-22.
 
18) De Hoogd S, Ahlers SJGM, van Dongen EPA, et al. Randomized controlled trial on the influence of intraoperative remifentanil versus fentanyl on acute and chronic pain after cardiac surgery. Pain Practice. 2018 ; 18 : 443-51.
PubMed
19) Engoren M, Luther G, Fenn-Buderer N. A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia. Anesth Analg. 2001 ; 93 : 859-64.
PubMed
P.54 掲載の参考文献
1) Larach DR, Schuler HG. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology. 1991 ; 75 : 268-78.
PubMed
2) Conzen PF, Vollmar B, Habazettl H, et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg. 1992 ; 74 : 79-88.
PubMed
3) Crawford MW, Lerman J, Saldivia V, et al. Hemodynamic and organ blood flow response to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesth Analg. 1992 ; 75 : 1000-6.
PubMed
4) Kersten JR, Brayer AP, Pagel PS, et al. Perfusion of ischemic myocardium during anesthesia with sevoflurane. Anesthesiology. 1994 ; 81 : 995-1004.
PubMed
5) Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia : a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 ; 74 : 1124-36.
PubMed
6) Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion : comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003 ; 285 : H579-88.
PubMed
7) Hausenloy DJ, Boston-Griffiths E, Yellon DM. Cardioprotection during cardiac surgery. Cardiovasc Res. 2012 ; 94 : 253-65.
PubMed
8) Warltier DC, Al-Wathiqui MH, Kampine JP, et al. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology. 1988 ; 65 : 552-65.
 
9) Kersten JR, Lowe D, Hettrick DA, et al. Glyburide, a Katp channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg. 1996 ; 83 : 27-33.
PubMed
10) Cope DK, Impastato WK, Cohen MV, et al. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology. 1997 ; 86 : 699-709.
PubMed
11) Toller WG, Kersten JR, Pagel PS, et al. Sevoflurane reduces myocardial infarct size and decrease the time threshold for ischemic preconditioning in dogs. Anesthesiology. 1999 ; 91 : 1437-46.
PubMed
12) Hara T, Tomiyasu S, Cho S, et al. Sevoflurane protects stunned myocardium through activation of mitochondrial ATP-sensitive potassium channels. Anesth Analg. 2001 ; 92 : 1139-45.
 
13) Toller WG, Gross ER, Kersten JR, et al. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels : mechanism of desflurane-induced cardioprotection. Anesthesiology. 2000 ; 92 : 1731-9.
PubMed
14) Novalija E, Hogan QH, Kulier AH, et al. Effects of desflurane, sevoflurane and halothane on postinfarction spontaneous dysrhythmias in dogs. Acta Anaesthesiol Scand. 1998 ; 42 : 353-7.
PubMed
15) Agarwal B, Stowe DF, Dash RK, et al. Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury. Front Physiol. 2014 ; 5 : 341.
PubMed
16) Lemoine S, Tritapepe L, Hanouz JL, et al. The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion : anaesthetic post-conditioning potentially translatable to humans? Br J Anaesth. 2016 ; 116 : 456-75.
PubMed
17) De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology. 2004 ; 101 : 9-20.
PubMed
18) Tempe D, Dutta D, Garg M, et al. Myocardial protection with isoflurane during off-pump coronary artery bypass grafting : a randomized trial. J Cardiothorac Vasc Anesth. 2011 ; 25 : 59-65.
 
19) Zangrillo A, Musu M, Greco T, et al. Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery : a Bayesian network meta-analysis of randomized trials. PLoS One. 2015 ; 10 : e0134264.
PubMed
20) Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG : a meta-analysis. Can J Anesth. 2006 ; 53 : 906-18.
PubMed
21) Landoni G, Greco T, Biondi-Zoccai G, et al. Anaesthetic drugs and survival : a Bayesian network meta-analysis of randomized trials in cardiac surgery. Br J Anaesth. 2013 ; 111 : 886-96.
PubMed
22) Landoni G, Lomivorotov VV, Nigro Neto C, et al. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N Engl J Med. 2019 ; 380 : 1214-25,
PubMed
23) Lindholm EE, Aune E, Noren CB, et al. The anesthesia in abdominal aortic surgery (ABSENT) study : a prospective, randomized, controlled trial comparing troponin t release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery. Anesthesiology. 2013 ; 119 : 802-12.
PubMed
24) Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 ; 130 : 2215-45.
 
25) Uhlig C, Bluth T, Schwarz K, et al. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery : a systematic review and meta-analysis. Anesthesiology. 2016 ; 124 : 1230-45.
PubMed
26) Amour J, Brzezinska AK, Jager Z, et al. Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms. Anesthesiology. 2010 ; 112 : 576-85.
PubMed
27) Raphael J, Gozal Y, Navot N, et al. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol. 2010 ; 55 : 348-57.
PubMed
28) Raphael J, Gozal Y, Navot N, et al. Activation of adenosine triphosphate-regulated potassium channels during reperfusion restores isoflurane postconditioning-induced cardiac protection in acutely hyperglycemic rabbits. Anesthesiology. 2015 ; 122 : 1299-311.
PubMed
29) Drenger B, Ostrovsky IA, Barak M, et al. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart : phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology. 2011 ; 114 : 1364-72.
 
30) Canfield SG, Zaja I, Godshaw B, et al. High glucose attenuates anesthetic cardioprotection in stem-cell-derived cardiomyocytes : the role of reactive oxygen species and mitochondrial fission. Anesth Analg. 2016 ; 122 : 1269-79.
PubMed
31) Ge ZD, Li Y, Qiao S, et al. Failure of isoflurane cardiac preconditioning in obese type 2 diabetic mice involves aberrant regulation of microRNA-21, endothelial nitric-oxide synthase, and mitochondrial complex I. Anesthesiology. 2018 ; 128 : 117-29.
PubMed
32) Mio Y, Bienengraeber MW, Marinovic J, et al. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology. 2008 ; 108 : 612-20.
PubMed
33) Nguyen LT, Rebecchi MJ, Moore LC, et al. Attenuation of isoflurane-induced preconditioning and reactive oxygen species production in the senescent rat heart. Anesth Analg. 2008 ; 107 : 776-82.
PubMed
34) Liu L, Zhu J, Glass PSA, et al. Age-associated changes in cardiac gene expression after preconditioning. Anesthesiology. 2009 ; 111 : 1052-64.
 
35) Rivo J, Raphael J, Drenger B, et al. Flumazenil mimics whereas midazolam abolishes ischemic preconditioning in a rabbit heart model of ischemiareperfusion. Anesthesiology. 2006 ; 105 : 65-71.
 
36) Kohro S, Hogan QH, Nakae Y, et al. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology. 2001 ; 95 : 1435-40.
PubMed
37) Zaugg M, Wang L, Zhang L, et al. Choice of anesthetic combination determines Ca2+ leak after ischemia-reperfusion injury in the working rat heart : favorable versus adverse combinations. Anesthesiology. 2012 ; 116 : 648-57.
PubMed
38) Likhvantsev VV, Landoni G, Levikov DI, et al. Sevoflurane versus total intravenous anesthesia for isolated coronary artery bypass surgery with cardiopulmonary bypass : a randomized trial. J Cardiothorac Vasc Anesth. 2016 ; 130 : 1221-7.
 
P.63 掲載の参考文献
1) Pieri M, De Simone A, Rose S, et al. Trials focusing on prevention and treatment of delirium after cardiac surgery : a systematic review of randomized evidence. J Cardiothorac Vasc Anesth. 2020 ; 34 : 1641-54.
PubMed
2) Wu M, Liang Y, Dai Z, et al. Perioperative dexmedetomidine reduces delirium after cardiac surgery : a meta-analysis of randomized controlled trials. J Clin Anesth. 2018 ; 50 : 33-42.
PubMed
3) Duan X, Coburn M, Rossaint R, et al. Efficacy of perioperative dexmedetomidine on postoperative delirium : systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth. 2018 ; 121 : 384-97.
PubMed
4) Liu Y, Zhang L, Wang S, et al. Dexmedetomidine reduces atrial fibrillation after adult cardiac surgery : a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs. 2020 ; 20 : 271-81.
PubMed
5) Zi J, Fan Y, Dong C, et al. Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft. Int Heart J. 2020 ; 61 : 263-72.
PubMed
6) Okada H, Kurita T, Mochizuki T, et al. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation. 2007 ; 74 : 538-45.
PubMed
7) Bunte S, Behmenburg F, Majewski N, et al. Characteristics of dexmedetomidine postconditioning in the field of myocardial ischemia-reperfusion injury. Anesth Analg. 2020 ; 130 : 90-8.
PubMed
8) Ji F, Li Z, Nguyen H, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013 ; 127 : 1576-84.
 
9) Tosun Z, Baktir M, Kahraman HC, et al. Does dexmedetomidine provide cardioprotection in coronary artery bypass grafting with cardiopulmonary bypass? A pilot study. J Cardiothorac Vasc Anesth. 2013 ; 27 : 710-5.
PubMed
10) Ren J, Zhang H, Huang L, et al. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Exp Ther Med. 2013 ; 6 : 497-502.
PubMed
11) Elgebaly AS, Fathy SM, Sallam AA, et al. Cardioprotective effects of propofol-dexmedetomidine in open-heart surgery : a prospective double-blind study. Ann Card Anaesth. 2020 ; 23 : 134-41.
PubMed
12) Zhou HM, Ling XY, Ni YJ, et al. Pre-cardiopulmonary bypass administration of dexmedetomidine decreases cardiac troponin I level following cardiac surgery with sevoflurane postconditioning. J Int Med Res. 2019 ; 47 : 3623-35.
PubMed
13) Ge ZD, Li Y, Qiao S, et al. Failure of isoflurane cardiac preconditioning in obese type 2 diabetic mice involves aberrant regulation of microRNA-21, endothelial nitric-oxide synthase, and mitochondrial complex I. Anesthesiology. 2018 ; 128 : 117-29.
PubMed
14) Ma L, Kong F, Ge H, et al. Ventricular hypertrophy blocked delayed anesthetic cardioprotection in rats by alteration of iNOS/COX-2 signaling. Sci Rep. 2014 ; 4 : 7071.
PubMed
15) Yoshikawa Y, Hirata N, Kawaguchi R, et al. Dexmedetomidine maintains its direct cardioprotective effect against ischemia/reperfusion injury in hypertensive hypertrophied myocardium. Anesth Analg. 2018 ; 126 : 443-52.
PubMed
16) Deng L, Chen H, Wei N, et al. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts. Microvasc Res. 2019 ; 123 : 1-6.
 
P.70 掲載の参考文献
1) Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008 ; 358 : 2319-31.
PubMed
2) Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding : systematic review and cumulative meta-analysis. BMJ. 2012 ; 344 : e3054.
PubMed
3) Society of Thoracic Surgeons Blood Conservation Guideline Task Force. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011 ; 91 :944-82.
 
4) Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding : guidelines from the European Society of Anaesthesiology : first update 2016. Eur J Anaesthesiol. 2017 ; 34 : 332-95.
PubMed
5) Dunn CJ, Goa KL. Tranexamic acid : a review of its use in surgery and other indications. Drugs. 1999 ; 57 : 1005-32.
 
6) Fiechtner BK, Nuttall GA, Johnson ME, et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg. 2001 ; 92 : 1131-6.
PubMed
7) Ng W, Jerath A, Wasowicz M. Tranexamic acid : a clinical review. Anaesthesiol Intensive Ther. 2015 ; 47 : 339-50.
PubMed
8) Jimenez JJ, Iribarren JL, Brouard M. et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients : a randomized doubleblind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg. 2011 ; 6 : 138.
PubMed
9) Katsaros D, Petricevic M, Snow NJ, et al. Tranexamic acid reduces postbypass blood use : a double-blinded, prospective, randomized study of 210 patients. Ann Thorac Surg. 1996 ; 61 : 1131-5.
PubMed
10) Spence J, Long S, Tidy A, et al. Tranexamic acid administration during on-pump cardiac surgery : a survey of current practices among Canadian anesthetists working in academic centers. Anesth Analg. 2017 ; 125 : 1863-70.
PubMed
11) Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017 ; 376 : 136-48.
PubMed
12) Adler Ma SC, Brindle W, Burton G, et al. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery : a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2011 ; 25 : 26-35.
PubMed
13) Dai Z, Chu H, Wang S, et al. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery : a systematic review and cumulative meta-analysis. J Clin Anesth. 2018 ; 44 : 23-31.
PubMed
14) Guo J, Gao X, Ma Y, et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery : a meta-analysis of randomized trials. BMC Anesthesiol. 2019 ; 19 : 129.
 
15) Lecker I, Wang DS, Romaschin AD, et al. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest. 2012 ; 122 : 4654-66.
PubMed
16) Koster A, Borgermann J, Zittermann A, et al. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures : incidence and clinical outcome. Br J Anaesth. 2013 ; 110 : 34-40.
PubMed
17) Sharma V, Katznelson R, Jerath A, et al. The association between tranexamic acid and convulsive seizures after cardiac surgery : a multivariate analysis in 11,529 patients. Anaesthesia. 2014 ; 69 : 124-30.
PubMed
18) Jerath A, Yang QJ, Pang KS, et al. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction : a new dosing regimen. Anesth Analg. 2018 ; 127 : 1323-32.
PubMed
19) Lecker I, Wang DS, Whissell PD, et al. Tranexamic acid-associated seizures : causes and treatment. Ann Neurol. 2016 ; 79 : 18-26.
PubMed
20) Hodgson S, Larvin JT, Dearman C. What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2015 ; 21 : 384-8.
PubMed
21) Giordano R, Palma G, Poli V, et al. Tranexamic acid therapy in pediatric cardiac surgery : a single-center study. Ann Thorac Surg. 2012 ; 94 : 1302-6.
PubMed
22) Faraoni D, Willems A, Melot C, et al. Efficacy of tranexamic acid in paediatric cardiac surgery : a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2012 ; 42 : 781-6.
PubMed
P.76 掲載の参考文献
1) Bignami E, Castella A, Pota V, et al. Perioperative pain management in cardiac surgery : a systematic review. Minerva Anestesiol. 2018 ; 84 : 488-503.
PubMed
2) Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications : a systematic update of the evidence. Anesth Analg. 2007 ; 104 : 689-702.
PubMed
3) Ball M, Falkson SR, Adigun OO. Anatomy, angle of Louis. In : StatPearls. Treasure Island (FL) : StatPearls Publishing ; 2020.
 
4) Guimaraes-Pereira L, Reis P, Abelha F, et al. Persistent postoperative pain after cardiac surgery : a systematic review with meta-analysis regarding incidence and pain intensity. Pain. 2017 ; 158 : 1869-85.
PubMed
5) Haroutiunian S, Nikolajsen L, Finnerup NB, et al. The neuropathic component in persistent postsurgical pain : a systematic literature review. Pain. 2013 ; 154 : 95-102.
PubMed
6) Lauridsen MH, Kristensen AD, Hjortdal VE, et al. Chronic pain in children after cardiac surgery via sternotomy. Cardiol Young. 2014 ; 24 : 893-9.
PubMed
7) Kwanten LE, O'Brien B, Anwar S. Opioid-based anesthesia and analgesia for adult cardiac surgery : history and narrative review of the literature. J Cardiothorac Vasc Anesth. 2019 ; 33 : 808-16.
PubMed
8) Noss C, Prusinkiewicz C, Nelson G, et al. Enhanced recovery for cardiac surgery. J Cardiothorac Vasc Anesth. 2018 ; 32 : 2760-70.
PubMed
9) Levene JL, Weinstein EJ, Cohen MS, et al. Local anesthetics and regional anesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children : A Cochrane systematic review and meta-analysis update. J Clin Anesth. 2019 ; 55 : 116-27.
PubMed
10) Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery : a Cochrane systematic review and meta-analysis. Br J Anaesth. 2013 ; 111 : 711-20.
PubMed
11) Freise H, Van Aken HK. Risks and benefits of thoracic epidural anaesthesia. Br J Anaesth. 2011 ; 107 : 859-68.
PubMed
12) Monaco F, Pieri M, Barucco G, et al. Epidural analgesia in open thoraco-abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2019 ; 57 : 360-7.
PubMed
13) Liu H, Emelife PI, Prabhakar A, et al. Regional anesthesia considerations for cardiac surgery. Best Pract Res Clin Anaesthesiol. 2019 ; 33 : 387-406.
PubMed
14) Flaherty J, Horn JL, Derby R. Regional anesthesia for vascular surgery. Anesthesiol Clin. 2014 ; 32 : 639-59.
PubMed
15) Okitsu K, Iritakenishi T, Iwasaki M, et al. Risk of hematoma in patients with a bleeding risk undergoing cardiovascular surgery with a paravertebral catheter. J Cardiothorac Vasc Anesth. 2017 ; 31 : 453-7.
PubMed
16) El Shora HA, El Beleehy AA, Abdelwahab AA, et al. Bilateral paravertebral block versus thoracic epidural analgesia for pain control post-cardiac surgery : a randomized controlled trial. Thorac Cardiovasc Surg. 2018 ; 10.1055/S-0038-1668496.
 
17) Scarfe AJ, Schuhmann-Hingel S, Duncan JK, et al. Continuous paravertebral block for post-cardiothoracic surgery analgesia : a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2016 ; 50 : 1010-8.
PubMed
18) Kumar KN, Kalyane RN, Singh NG, et al. Efficacy of bilateral pectoralis nerve block for ultrafast tracking and postoperative pain management in cardiac surgery. Ann Card Anaesth. 2018 ; 21 : 333-8.
PubMed
19) Fujiwara A, Komasawa N, Minami T. Pectoral nerves (PECS) and intercostal nerve block for cardiac resynchronization therapy device implantation. Springerplus. 2014 ; 3 : 409.
PubMed
20) Yalamuri S, Klinger RY, Bullock WM, et al. Pectoral fascial (PECS) I and II blocks as rescue analgesia in a patient undergoing minimally invasive cardiac surgery. Reg Anesth Pain Med. 2017 ; 42 : 764-6.
 
21) Moll V, Maffeo C, Mitchell M, et al. Association of serratus anterior plane block for minimally invasive direct coronary artery bypass surgery with higher opioid consumption : a retrospective observational study. J Cardiothorac Vasc Anesth. 2018 ; 32 : 2570-7.
PubMed
22) Kaushal B, Chauhan S, Saini K, et al. Comparison of the efficacy of ultrasound-guided serratus anterior plane block, pectoral nerves ii block, and intercostal nerve block for the management of postoperative thoracotomy pain after pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 2019 ; 33 : 418-25.
PubMed
23) Krishna SN, Chauhan S, Bhoi D, et al. Bilateral erector spinae plane block for acute post-surgical pain in adult cardiac surgical patients : a randomized controlled trial. J Cardiothorac Vasc Anesth. 2019 ; 33 : 368-75.
PubMed
24) Mittnacht AJC, Shariat A, Weiner MM, et al. Regional techniques for cardiac and cardiac-related procedures. J Cardiothorac Vasc Anesth. 2019 ; 33 : 532-46.
PubMed
25) Barr AM, Tutungi E, Almeida AA. Parasternal intercostal block with ropivacaine for pain management after cardiac surgery : a double-blind, randomized, controlled trial. J Cardiothorac Vasc Anesth. 2007 ; 21 : 547-53.
PubMed
26) Chaudhary V, Chauhan S, Choudhury M, et al. Parasternal intercostal block with ropivacaine for postoperative analgesia in pediatric patients undergoing cardiac surgery : a double-blind, randomized, controlled study. J Cardiothorac Vasc Anesth. 2012 ; 26 : 439-42.
PubMed
27) Nachiyunde B, Lam L. The efficacy of different modes of analgesia in postoperative pain management and early mobilization in postoperative cardiac surgical patients : a systematic review. Ann Card Anaesth. 2018 ; 21 : 363-70.
PubMed
28) Ellard L, Djaiani G. Anaesthesia for vascular emergencies. Anaesthesia. 2013 ; 68 Suppl 1 : 72-83.
 
29) Lippmann M, Lingam K, Rubin S, et al. Anesthesia for endovascular repair of abdominal and thoracic aortic aneurysms : a review article. J Cardiovasc Surg. 2003 ; 44 : 443-51.
PubMed
30) Sen A, Erdivanli B, Ozdemir A, et al. Efficacy of continuous epidural analgesia versus total intravenous analgesia on postoperative pain control in endovascular abdominal aortic aneurysm repair : a retrospective case-control study. Biomed Res Int. 2014 ; 2014 : 205164.
 
31) Villablanca PA, Mohananey D, Nikolic K, et al. Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement : a meta-analysis. Catheter Cardiovasc Interv. 2018 ; 91 : 330-42.
PubMed
32) Berthoud V, Ellouze O, Bievre T, et al. Serratus anterior plane block for apical TAVR in an awake patient. J Cardiothorac Vasc Anesth. 2018 ; 32 : 2275-7.
 
33) Tulgar S, Ahiskalioglu A, Selvi O, et al. Similarities between external oblique fascial plane block and blockage of thoracoabdominal nerves through perichondral approach (TAPA). J Clin Anesth. 2019 ; 57 : 91-2.
 
34) Tulgar S, Selvi O, Thomas DT, et al. Modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) provides effective analgesia in abdominal surgery and is a choice for opioid sparing anesthesia. J Clin Anesth. 2019 ; 55 : 109.
PubMed
35) Elsharkawy H, Saifullah T, Kolli S, et al. Rhomboid intercostal block. Anaesthesia. 2016 ; 71 : 856-7.
PubMed

モニタリング

P.86 掲載の参考文献
1) Connors AF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996 ; 276 : 889-97.
PubMed
2) Sandham JD, Hull RD, Brant RF et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003 ; 348 : 5-14.
PubMed
3) Shaw AD, Mythen MG, Shook D, et al. Pulmonary artery catheter use in adult patients undergoing cardiac surgery : a retrospective, cohort study. Perioper Med (LOND). 2018 ; 7 : 24.
PubMed
4) Ikuta K, Wang Y, Robinson A, et al. National trends in use and outcomes of pulmonary artery catheters among medicare beneficiaries. JAMA Cardiol. 2017 ; 2 : 908-13.
PubMed
5) Hadian M, Pinsky MR. Evidence-based review of the use of the pulmonary artery catheter : impact data and complications. Crit Care. 2006 ; 10 (Suppl 3) : S8.
 
6) Karney TJ, Shabot MM. Pulmonary artery rupture associated with the Swan-Ganz catheter. Chest. 1995 ; 108 : 1349-52.
 
7) 日本心臓血管外科学会・日本心臓血管麻酔学会合同ステートメント作成委員会. 心臓手術時の肺動脈カテーテル使用に関するステートメント. 2020年3月.
 
8) Gnaegi A, Feil F, Perret C. Intensive care physicians' insufficient knowledge of right-heart catheterization at the bedside : time to act? Crit Care Med. 1997 ; 25 : 213-20.
 
9) Leurent G, Delmas C, Auffret V, et al. The 50-year -old pulmonary artery catheter : the tale of a fore told death? Curr Opin Crit Care. 2018 ; 24 : 204-8.
 
10) Backer DD, Vincent JL. The pulmonary artery catheter : is it still alive? Curr Opin Crit Care. 2018 ; 24 : 204-8.
 
11) Yanik B, Paul EM. Bedside ultrasonography in the ICU : Part 1. Chest. 2005 ; 128 ; 881-95.
 
12) Brovman EY, Gabriel RA, Dutton RP, et al. Pulmonary artery catheter use during cardiac surgery in the United States, 2010 to 2014. J Cardiothorac Vasc Anesth. 2016 ; 30 : 579-84.
PubMed
13) Bossone E, Nanda NC, Naeije R. Imaging the right heart : a challenging road map. Echocardiography. 2015 ; 32 (Suppl 1) : S1-2.
 
14) Ospina-Tascon GA, Cordioli RL, Vincent JL, et al. What type of monitoring has been shown to improve outcomes in actually ill patients? Intensive Care Med. 2008 ; 34 : 800-20.
 
15) Cannesson M, Pestel G, Ricks C, et al. Hemodynamic monitoring and management in patients undergoing high risk surgery : a survey among North American and European anesthesiologists. Crit Care. 2011 ; 15 : R197.
PubMed
16) American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Practice guidelines for pulmonary artery catheterization. Anesthesiology. 2003 ; 99 : 988-1014.
PubMed
17) Schwann TA, Zacharias A, Riordan CJ, et al. Safe, highly selective use of pulmonary artery catheters in coronary artery bypass grafting : an objective patient selection method. Ann Thorac Surg. 2002 ; 73 : 1394-402.
PubMed
18) Hamilton MA, Cecconi M, Rhodese A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011 ; 112 : 1392-402.
 
19) Ranucci M. Which cardiac surgical patients can benefit from placement of a pulmonary artery catheter? Crit Care. 2006 ; 10 (Suppl 3) : S6.
 
20) Kanchi M. Do we need a pulmonary artery catheter in cardiac anesthesia? -An Indian perspective. Ann Card Anaesth. 2011 ; 14 : 25-9.
 
21) Hills LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery. Circulation. 2011 ; 124 : e652-e735.
 
22) Vincent JL, Pinsky MR, Sprung CL, et al. The pulmonary artery catheter : in medio virtus. Crit Care Med. 2008 ; 36 : 3093-6.
PubMed
P.93 掲載の参考文献
1) Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012 : an assessment supporting improved health outcomes. Lancet. 2015 ; 385 Suppl 2 : S11.
 
2) Schroeder RA, Pollard R, Dhakal I, et al. Temporal trends in difficult and failed tracheal intubation in a regional community anesthetic practice. Anesthesiology. 2018 ; 128 : 502-10.
 
3) Bennett-Guerrero E, Welsby I, Dunn TJ, et al. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg. 1999 ; 89 : 514-9.
PubMed
4) Gan TJ, Mythen MG. Does peroperative gut-mucosa hypoperfusion cause postoperative nausea and vomiting? Lancet. 1995 ; 345 : 1123-4.
PubMed
5) Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man) : a randomised controlled trial. Lancet. 2005 ; 366 : 472-7.
 
6) Suehiro K, Tanaka K, Mukai A, et al. Hemodynamic monitoring and management in high-risk surgery : a survey among Japanese anesthesiologists. J Anesth. 2016 ; 30 : 526-9.
PubMed
7) Suehiro K, Tanaka K, Matsuura T, et al. The Vigileo-FloTracTM system : arterial waveform analysis for measuring cardiac output and predicting fluid responsiveness : a clinical review. J Cardiothorac Vasc Anesth. 2014 ; 28 : 1361-74.
 
8) Suehiro K, Tanaka K, Funao T, et al. Systemic vascular resistance has an impact on the reliability of the Vigileo-FloTrac system in measuring cardiac output and tracking cardiac output changes. Br J Anaesth. 2013 ; 111 : 170-7.
PubMed
9) Biais M, Mazocky E, Stecken L, et al. Impact of systemic vascular resistance on the accuracy of the Pulsioflex device. Anesth Analg. 2017 ; 124 : 487-93.
PubMed
10) Cannesson M, Musard H, Desebbe O, et al. The ability of stroke volume variations obtained with Vigileo/FloTrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg. 2009 ; 108 : 513-7.
PubMed
11) Mair S, Tschirdewahn J, Gotz S, et al. Applicability of stroke volume variation in patients of a general intensive care unit : a longitudinal observational study. J Clin Monit Comput. 2017 ; 31 : 1177-87.
PubMed
12) Mathis MR, Duggal NM, Likosky DS, et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology. 2019 ; 131 : 1046-62.
PubMed
13) Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness : an update. Ann Intensive Care. 2016 ; 6 : 111.
PubMed
14) Nielsen J, Nilsson M, Freden F, et al. Central hemodynamics during lung recruitment maneuvers at hypovolemia, normovolemia and hypervolemia. A study by echocardiography and continuous pulmonary artery flow measurements in lung-injured pigs. Intensive Care Med. 2006 ; 32 : 585-94.
PubMed
15) Biais M, Lanchon R, Sesay M, et al. Changes in stroke volume induced by lung recruitment maneuver predict fluid responsiveness in mechanically ventilated patients in the operating room. Anesthesiology. 2017 ; 126 : 260-7.
PubMed
16) Biais M, Larghi M, Henriot J, et al. End-expiratory occlusion test predicts fluid responsiveness in patients with protective ventilation in the operating room. Anesth Analg. 2017 ; 125 : 1889-95.
PubMed
17) Biais M, de Courson H, Lanchon R, et al. Mini-fluid challenge of 100 ml of crystalloid predicts fluid responsiveness in the operating room. Anesthesiology. 2017 ; 127 : 450-6.
PubMed
18) Joosten A, Rinehart J, Bardaji A, et al. Anesthetic management using multiple closed-loop systems and delayed neurocognitive recovery : a randomized controlled trial. Anesthesiology. 2020 ; 132 : 253-66.
PubMed
19) Joosten A, Alexander B, Duranteau J, et al. Feasibility of closed-loop titration of norepinephrine infusion in patients undergoing moderate- and high-risk surgery. Br J Anaesth. 2019 ; 123 : 430-8.
PubMed
20) Joosten A, Jame V, Alexander B, et al. Feasibility of fully automated hypnosis, analgesia, and fluid management using 2 independent closed-loop systems during major vascular surgery : a pilot study. Anesth Analg. 2019 ; 128 : e88-e92.
PubMed
P.107 掲載の参考文献
1) 2020年改訂版 弁膜症治療のガイドライン. 2020. https://www.j-circ.or.jp/old/guideline/pdf/JCS2020_Izumi_Eishi.pdf (2020年7月16日閲覧)
 
2) Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014 ; 148 : e1-132.
 
3) Sabbagh AE, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era : insights into diagnosis, management and future directions. J Am Coll Cardiol Img. 2018 ; 11 : 628-43.
 
4) Carpentier A. Cardiac valve surgery-The French Correction. J Thorac Cardiovasc Surg. 1983 ; 86 : 323-37.
PubMed
5) Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination : recommendations from the American Society of Echocardiography and the Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013 ; 26 : 921-64.
 
6) Omran AS, Woo A, David TE, et al. Intraoperative transesophageal echocardiography accurately predicts mitral valve anatomy and suitability for repair. J Am Soc Echocardiogr. 2002 ; 15 : 950-7.
PubMed
7) Shimokawa T, Kasagawa H, Katayama Y, et al. Mechanisms of recurrent regurgitation after valve repair for prolapsed mitral valve disease. Ann Thorac Surg. 2011 ; 91 : 1433-8.
 
8) Faletra FF, Demertzis S, Pedrazzini G, et al. Three-dimensional transesopphageal echocardiography in degenerative mitral regurgitation. J Am Soc Echocardiogr. 2015 ; 28 : 437-48.
PubMed
9) Kasel AM, Cassese S, Bleiziffer S, et al. Standardized imaging for aortic annular sizing : implications for transcatheter valve selection. JACC Cardiovasc Imaging. 2013 ; 6 : 249-62.
PubMed
10) Boodhwani M, de Kerchove L, Glinerr D, et al. Repair-oriented classification of aortic insufficiency : impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg. 2009 ; 137 : 286-94.
 
11) Vahnian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Euro Heart J. 2012 ; 33 : 2451-96.
 
12) Le Polain de Waroux JB, Pouleur AC, Goffinet C, et al. Functional anatomy of aortic regurgitation : accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation. 2007 ; 11 : I264-9.
 
13) Schafers HG, Schmied W, Marom G, et al. Cusp height in aortic valves. J Thorac Cardiovasc Surg. 2013 ; 2 : 269-74.
 
14) Preoperative aortic root geometry and postoperative cusp configuration primarily determine long-term outcome after valve-preserving aortic root repair. J Thorac Cardiovasc Surg. 2012 ; 6 : 1389-95.
PubMed
15) Le Polain de Waroux JB, Pouleur AC, Robert A, et al. Mechanisms of reccurent aortic regurgitation after aortic valve repair : predictive valve of intraoperative transesophageal echocardiography. JACC Cardiovasc Imaging. 2009 ; 2 : 931-9.
 
16) Pettersson GB, Crucean AC, Savage R, et al. Toward predictable repair of regurgitant aortic valves : a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol. 2008 ; 52 : 40-9.
PubMed
17) Habib G, Lancellotti P, Antunes MJ, et al. 2015 Guidelines for the management of infective endocarditis : The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Enclosed by European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 ; 36 : 3075-128.
 
18) Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults : diagnosis, antimicrobial therapy, and management of complications : a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015 ; 132 : 1435-86.
PubMed
19) Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system : safety and midterm durability in the initial EVEREST (Endovasucular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009 ; 54 : 686-94.
 
20) Boekstegers P, Hausleiter J, Baldus S, et al. Perculaneous interventional mitral regurgitation treatment using the MitralClip system. Clin Res Cardiol. 2014 ; 103 : 85-96.
 
21) Hahn RT, Little SH, Monaghan MJ, et al. Recommendations for comprehensive intraprocedual echocardiographic imaging during TAVR. JACC Cardiovasc Imaging. 2015 ; 8 : 261-87.
 
22) Jilaihawi H, Doctor N, Kashif M, et al. Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Cardiol. 2013 ; 61 : 908-16.
PubMed
23) Coretes C, Amat-Santos IJ, Nombela-Franco L, et al. Mitral regurgitation after transcatheter aortic valve replacement : prognosis, imaging, predictors, and potential management. JACC Cardiovasc Interv. 2016 ; 9 : 1603-14.
 
24) Kiramijyan S, Koifman E, Asch FM, et al. Impact of functional versus organic baseline mitral regurgitation on short-term and long-term outcomes after transcatheter aortic valve replacement. Am J Cardiol. 2016 ; 117 : 839-46.
PubMed
25) Plbarot P, Hahn RT, Welessman NJ, et al. Assessment of paravalvular regurgitation following TAVR : a proposal of unifying grading scheme. JACC Cardiovasc Imaging. 2015 ; 8 : 340-60.
 
26) Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 ; 58 : e123-210.
 
27) American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology. 2010 ; 112 : 1084-96.
 
28) Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac surgery ; European Society of Cardiology (ESC), Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J. 2009 ; 30 : 2768-812.
 
29) Jasudavisus A, Arellano R, Martin J, et al. A systemic review of transthoracic and transesophageal echocardiography in non-cardiac surgery : implications for point-of-care ultrasound education in the operating room. Can J Anaesth. 2016 ; 63 : 480-7.
 
30) Hofer CK, Zollinger A, Rak M, et al. Therapeutic impact of intra-operative transesophageal echocardiography during noncardiac surgery. Anaesthesia. 2004 ; 59 : 3-9.
PubMed
31) Suriani RJ, Neustein S, Shore-Lesserson L, et al. Intraoperative transesophageal echocardiography during noncardiac surgery. J Cardiothorac Vasc Anesth. 1998 ; 12 : 274-80.
PubMed
32) Gudmundsson P, Rydberg E, Winter R, et al. Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol. 2005 ; 25 : 209-12.
 
33) Reeves ST, Finley AC, Skubas NJ, et al. Special article : basic perioperative transesophageal echocardiography examination : a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg. 2013 ; 117 : 543-58.
 
34) Lecharny JB, Philip I, Depoix JP. Oesophagotracheal perforation after intraoperative transoesophageal echocardiography in cardiac surgery. Br J Anaesth. 2002 ; 88 : 529-4.
 
35) Massey SR, Pitsis A, Mehta D, et al. Oesphageal perforation following perioperative transoesophageal echocardiography. Br J Anaesth. 2000 ; 84 : 643-6.
 
36) Puchalski MD, Lui GK, Miller-Hance WC, et al. Guidelines for performing a comprehensive transesophageal echocardiographic : examination in children and all patients with congenital heart disease : recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019 ; 32 : 173-215.
PubMed
P.117 掲載の参考文献
1) Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion. 2012 ; 52 : 14-22.
PubMed
2) Ogawa S, Ohnishi T, Hosokawa K, et al. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. Br J Anaesth. 2013 ; 111 : 1013-23.
PubMed
3) Takeshita S, Ogawa S, Nakayama Y, et al. Prohemostatic activity of factor X in combination with activated factor VII in dilutional coagulopathy. Anesth Analg. 2019 ; 129 : 339-45.
PubMed
4) Aylsworth CL, Stefan F, Woitas K, et al. New technology, old standards : disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron. Ann Thorac Surg. 2004 ; 77 : 973-6.
PubMed
5) Groves DS, Welsby IJ, Naik BI, et al. Multicenter evaluation of the Quantra QPlus System in adult patients undergoing major surgical procedures. Anesth Analg. 2020 ; 130 : 899-909.
PubMed
6) Ogawa S, Szlam F, Bolliger D, et al. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry. Anesth Analg. 2012 ; 115 : 16-21.
PubMed
7) Ogawa S, Szlam F, Ohnishi T, et al. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost. 2011 ; 106 : 1215-23.
PubMed
8) Okabayashi S, Ogawa S, Tanaka KA, et al. A comparative study of point-ofcare prothrombin time in cardiopulmonary bypass surgery. J Cardiothorac Vasc Anesth. 2018 ; 32 : 1609-14.
 
9) 小川覚, 宮田茂樹. フィブリノゲンが止血に果たす役割-希釈性凝固障害における補充療法. 血栓止血誌. 2016 ; 27 : 328-38.
 
10) Ogawa S, Tanaka KA, Nakajima Y, et al. Fibrinogen measurements in plasma and whole blood : a performance evaluation study of the dry-hematology system. Anesth Analg. 2015 ; 120 : 18-25.
 
11) Takeshita S, Tanaka KA, Sawa T, et al. Whole blood point-of-care testing for incomplete reversal with idarucizumab in supratherapeutic dabigatran. Anesth Analg. 2020 ; 130 : 535-41.
PubMed
12) Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing : a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012 ; 117 : 531-47.
PubMed
13) Karkouti K, Callum J, Wijeysundera DN, et al. Point-of-care hemostatic testing in cardiac surgery : a stepped-wedge clustered randomized controlled trial. Circulation. 2016 ; 134 : 1152-62.
PubMed
14) Nakayama Y, Nakajima Y, Tanaka KA, et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015 ; 114 : 91-102.
PubMed
15) Ichikawa J, Marubuchi T, Nishiyama K, et al. Introduction of thromboelastometry-guided administration of fresh-frozen plasma is associated with decreased allogeneic blood transfusions and post-operative blood loss in cardiopulmonary-bypass surgery. Blood Transfus. 2018 ; 16 : 244-52.
PubMed
16) Serraino GF, Murphy GJ. Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery : updated systematic review and meta-analysis. Br J Anaesth. 2017 ; 118 : 823-33.
PubMed
17) Ogawa S, Richardson JE, Sakai T, et al. High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass. J Anesth. 2012 ; 26 : 9-19.
PubMed
P.124 掲載の参考文献
1) Yoshitani K, Kawaguchi M, Ishida K, et al. Guidelines for the use of cerebral oximetry by near-infrared spectroscopy in cardiovascular anesthesia : a report by the cerebrospinal division of the academic committee of the Japanese Society of Cardiovascular Anesthesiologists (JSCVA). J Anesth. 2019 ; 33 : 167-96.
PubMed
2) Bickler PE, Feiner JR, Rollins MD. Factors affecting the performance of 5 cerebral oximeters during hypoxia in healthy volunteers. Anesth Analg. 2013 ; 117 : 813-23.
PubMed
3) de Tournay-Jette E, Dupuis G, Bherer L, et al. The relationship between cerebral oxygen saturation changes and postoperative cognitive dysfunction in elderly patients after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011 ; 25 : 95-104.
PubMed
4) Fudickar A, Peters S, Stapelfeldt C, et al. Postoperative cognitive deficit after cardiopulmonary bypass with preserved cerebral oxygenation : a prospective observational pilot study. BMC Anesthesiol. 2011 ; 11 : 7.
PubMed
5) Schoen J, Husemann L, Tiemeyer C, et al. Cognitive function after sevoflurane- vs propofol-based anaesthesia for on-pump cardiac surgery : a randomized controlled trial. Br J Anaesth. 2011 ; 106 : 840-50.
PubMed
6) Schoen J, Meyerrose J, Paarmann H, et al. Preoperative regional cerebral oxygen saturation is a predictor of postoperative delirium in on-pump cardiac surgery patients : a prospective observational trial. Crit Care. 2011 ; 15 : R218.
 
7) Hong SW, Shim JK, Choi YS, et al. Prediction of cognitive dysfunction and patients' outcome following valvular heart surgery and the role of cerebral oximetry. Eur J Cardiothorac Surg. 2008 ; 33 : 560-5.
PubMed
8) Reents W, Muellges W, Franke D, et al. Cerebral oxygen saturation assessed by near-infrared spectroscopy during coronary artery bypass grafting and early postoperative cognitive function. Ann Thorac Surg. 2002 ; 74 : 109-14.
PubMed
9) Holmgaard F, Vedel AG, Rasmussen LS, et al. The association between postoperative cognitive dysfunction and cerebral oximetry during cardiac surgery : a secondary analysis of a randomised trial. Br J Anaesth. 2019 ; 123 : 196-205.
PubMed
10) Lei L, Katznelson R, Fedorko L, et al. Cerebral oximetry and postoperative delirium after cardiac surgery : a randomised, controlled trial. Anaesthesia. 2017 ; 72 : 1456-66.
PubMed
11) Haldenwang PL, Strauch JT, Mullem K, et al. Effect of pressure management during hypothermic selective cerebral perfusion on cerebral hemodynamics and metabolism in pigs. J Thorac Cardiovasc Surg. 2010 ; 139 : 1623-31.
PubMed
12) Strauch JT, Spielvogel D, Lauten A, et al. Optimal temperature for selective cerebral perfusion. J Thorac Cardiovasc Surg. 2005 ; 130 : 74-82.
PubMed
13) Xiong L, Liu X, Shang T, et al. Impaired cerebral autoregulation : measurement and application to stroke. J Neurol Neurosurg Psychiatry. 2017 ; 88 : 520-31.
PubMed
14) Joshi B, Brady K, Lee J, et al. Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke. Anesth Analg. 2010 ; 110 : 321-8.
PubMed
15) Ono M, Joshi B, Brady K, et al. Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke. Br J Anaesth. 2012 ; 109 : 391-8.
PubMed
16) Kumpaitiene B, Svagzdiene M, Sirvinskas E, et al. Cerebrovascular autoregulation impairments during cardiac surgery with cardiopulmonary bypass are related to postoperative cognitive deterioration : prospective observational study. Minerva Anestesiol. 2019 ; 85 : 594-603.
PubMed
17) Gottlieb EA, Fraser CD Jr, Andropoulos DB, et al. Bilateral monitoring of cerebral oxygen saturation results in recognition of aortic cannula malposition during pediatric congenital heart surgery. Paediatr Anaesth. 2006 ; 16 : 787-9.
PubMed
18) Davie SN, Grocott HP. Impact of extracranial contamination on regional cerebral oxygen saturation : a comparison of three cerebral oximetry technologies. Anesthesiology. 2012 ; 116 : 834-40.
PubMed
19) Kato S, Yoshitani K, Kubota Y, et al. Effect of posture and extracranial contamination on results of cerebral oximetry by near-infrared spectroscopy. J Anesth. 2017 ; 31 : 103-10.
PubMed
P.132 掲載の参考文献
1) Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995 ; 110 : 1302-11.
PubMed
2) Siepe M, Pfeiffer T, Gieringer A, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011 ; 40 : 200-7.
PubMed
3) Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients : a randomized controlled trial. Circulation. 2018 ; 137 : 1770-80.
PubMed
4) Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II : a randomized trial comparing intraoperative high versus customized mean arterial pressure. J Cardiac Surgery. 2007 ; 22 : 465-72.
 
5) Hori D, Nomura Y, Ono M, et al. Optimal blood pressure during cardiopulmonary bypass defined by cerebral autoregulation monitoring. J Thorac Cardiovasc Surg. 2017 ; 154 : 1590-8.
PubMed
6) Puis L, Milojevic M, Boer C, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Interact Cardiovasc Thorac Surg. 2020 ; 30 : 161-202.
PubMed
7) Kirklin JW, Patrick RT, Theye RA. Theory and practice in the use of a pump-oxygenator for open intracardiac surgery. Thorax. 1957 ; 12 : 93-8.
PubMed
8) 川島康生. 体外循環の血行動態に関する研究, とくに人工心肺装置を用いた時の適正灌流量の決定について. 胸部外科. 1961 ; 14 : 865-78.
 
9) Magruder JT, Crawford TC, Harness HL, et al. A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2017 ; 153 : 118-25.
PubMed
10) Ranucci M, Romitti F, Isgro G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005 ; 80 : 2213-20.
PubMed
11) de Somer F, Mulholland JW, Bryan MR, et al. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury : time for a goal-directed perfusion management? Crit Care. 2011 ; 15 : R192.
PubMed
12) Magruder JT, Dungan SP, Grimm JC, et al. Nadir oxygen delivery on bypass and hypotension increase acute kidney injury risk after cardiac operations. Ann Thorac Surg. 2015 ; 100 : 1697-703.
PubMed
13) Kanji HD, Schulze CJ, Hervas-Malo M, et al. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg. 2010 ; 5 : 71.
PubMed
14) Svenmarker S, Hannuksela M, Haney M. A retrospective analysis of the mixed venous oxygen saturation as the target for systemic blood flow control during cardiopulmonary bypass. Perfusion. 2018 ; 33 : 453-62.
 
15) McDaniel LB, Zwischenberger JB, Kramer GC, et al. Mixed venous oxygen saturation during cardiopulmonary bypass poorly predicts regional venous saturation. Anesth Analg. 1995 ; 80 : 466-72.
PubMed
16) Ranucci M, Isgro G, Giomarelli P, et al. Anaerobic metabolism during cardiopulmonary bypass : 5 predictive value of carbon dioxide derived parameters. Ann Thorac Surg. 2006 ; 81 : 2189-95.
PubMed
17) Kato T, Hayashi T, Koyamoto T, et al. A review of goal directed perfusion. Jpn J Extra-Corporeal Technology. 2017 ; 44 : 73-80.
 
18) Ranucci M, Johnson I, Willcox T, et al. Goal-directed perfusion to reduce acute kidney injury : a randomized trial. J Thorac Cardiovasc Surg. 2018 ; 156 : 1918-27.
 
19) Ranucci M, Castelvecchio S, Baryshnikova E, et al. Transfusions during cardiopulmonary bypass : better when triggered by venous oxygen saturation and oxygen extraction rate. Perfusion. 2011 ; 26 : 327-33.
PubMed
P.139 掲載の参考文献
1) Etz CD, Halstead JC, Spielvogel D, et al. Thoracic and thoracoabdominal aneurysm repair : is reimplantation of spinal cord arteries a waste of time? Ann Thorac Surg. 2006 ; 82 : 1670-7.
PubMed
2) Yoshitani K, Masui K, Kawaguchi M, et al. Clinical utility of intraoperative motor-evoked potential monitoring to prevent postoperative spinal cord injury in thoracic and thoracoabdominal aneurysm repair : an audit of the Japanese Association of Spinal Cord Protection in Aortic Surgery Database. Anesth Analg. 2018 ; 126 : 763-8.
PubMed
3) Jacobs MJ, Elenbaas TW, Schurink GW, et al. Assessment of spinal cord integrity during thoracoabdominal aortic aneurysm repair. Ann Thorac Surg. 2002 ; 74 : S1864-98.
PubMed
4) Maeda T, Yoshitani K, Sato S, et al. Spinal cord ischemia after endovascular aortic repair versus open surgical repair for descending thoracic and thoracoabdominal aortic aneurism. J Anesth. 2012 ; 26 : 805-11.
PubMed
5) Awad H, Ramadan ME, El Sayed HF, et al. Spinal cord injury after thoracic endovascular aortic aneurysm repair. Lesion de la moelle epiniere apres reparation endovasculaire d'un anevrisme de l'aorte thoracique. Can J Anaesth. 2017 ; 64 : 1218-35.
 
6) Etz CD, Weigang E, Hartert M, et al. Contemporary spinal cord protection during thoracic and thoracoabdominal aortic surgery and endovascular aortic repair : a position paper of the vascular domain of the European Association for Cardio-Thoracic Surgery. Eur J Cardiothorac Surg. 2015 ; 47 : 943-57.
PubMed
7) See RB, Awosika OO, Cambria RP, et al. Extended motor evoked potentials monitoring helps prevent delayed paraplegia after aortic surgery. Ann Neurol. 2016 ; 79 : 636-45.
PubMed
8) Tanaka Y, Kawaguchi M, Noguchi Y, et al. Systematic review of motor evoked potentials monitoring during thoracic and thoracoabdominal aortic aneurysm open repair surgery : a diagnostic meta-analysis. J Anesth. 2016 ; 30 : 1037-50.
PubMed
9) Macdonald DB, Skinner S, Shils J, et al. American Society of Neurophysiological Monitoring. Intraoperative motor evoked potential monitoring-a position statement by the American Society of Neurophysiological Monitoring. Clin Neurophysiol. 2013 ; 124 : 2291-316.
PubMed
10) 日本麻酔科学会. MEPモニタリング時の麻酔管理のためのプラクティカルガイド. https://anesth.or.jp/files/pdf/mep_monitoring_practical_guide.pdf (2020年6月30日閲覧)
 
11) Kawaguchi M, Iida H, Tanaka S, et al. A practical guide for anesthetic management during intraoperative motor evoked potential monitoring. J Anesth. 2020 ; 34 : 5-28.
 
P.145 掲載の参考文献
1) Dijkstra ML, Vainas T, Zeebregts CJ, et al. Editor's choice-spinal cord ischaemia in endovascular thoracic and thoraco-abdominal aortic repair : review of preventive strategies. Eur J Vasc Endovasc Surg. 2018 ; 55 : 829-41.
 
2) Yoshitani K, Masui K, Kawaguchi M, et al. Clinical utility of intraoperative motor-evoked potential monitoring to prevent postoperative spinal cord injury in thoracic and thoracoabdominal aneurysm repair : an audit of the Japanese Association of Spinal Cord Protection in Aortic Surgery Database. Anesth Analg. 2018 ; 126 : 763-8.
PubMed
3) Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2007 ; 83 : S862-4.
PubMed
4) Coselli JS, Green SY, Price MD, et al. Spinal cord deficit after 1114 extent II open thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg. 2020 ; 159 : 1-13.
PubMed
5) Eagleton MJ, Shah S, Petkosevek D, et al. Hypogastric and subclavian artery patency affects onset and recovery of spinal cord ischemia associated with aortic endografting. J Vasc Surg. 2014 ; 59 : 89-94.
PubMed
6) Drenger B, Parker SD, Frank SM, et al. Changes in cerebrospinal fluid pressure and lactate concentrations during thoracoabdominal aortic aneurysm surgery. Anesthesiology. 1997 ; 86 : 41-7.
PubMed
7) Coselli JS, LeMaire SA, Koksoy C, et al. Cerebrospinal fluid drainage reduces paraplegia after thoracoabdominal aortic aneurysm repair : results of a randomized clinical trial. J Vasc Surg. 2002 ; 35 : 631-9.
PubMed
8) Cina CS, Abouzahr L, Arena GO, et al. Cerebrospinal fluid drainage to prevent paraplegia during thoracic and thoracoabdominal aortic aneurysm surgery : a systematic review and meta-analysis. J Vasc Surg. 2004 ; 40 : 36-44.
PubMed
9) Etz CD, Weigang E, Hartert M, et al. Contemporary spinal cord protection during thoracic and thoracoabdominal aortic surgery and endovascular aortic repair : a position paper of the vascular domain of the European Association for Cardio-Thoracic Surgery. Eur J Cardiothorac Surg. 2015 ; 47 : 943-57.
PubMed
10) Suarez-Pierre A, Zhou X, Gonzalez JE, et al. Association of preoperative spinal drain placement with spinal cord ischemia among patients undergoing thoracic and thoracoabdominal endovascular aortic repair. J Vasc Surg. 2019 ; 70 : 393-403.
PubMed
11) Malloy PC, Raghavan A, Elder T, et al. Cerebrospinal fluid drainage during endovascular aortic aneurysm repair : a systematic review of the literature and treatment recommendations. Vasc Endovascular Surg. 2020 ; 54 : 205-13.
PubMed
12) Arora H, Ullery BW, Kumar PA, et al. Pro : patients at risk for spinal cord ischemia after thoracic endovascular aortic repairs should receive prophylactic cerebrospinal fluid drainage. J Cardiothorac Vasc Anesth. 2015 ; 29 : 1376-80.
PubMed
13) Scali ST, Wang SK, Feezor RJ, et al. Preoperative prediction of spinal cord ischemia after thoracic endovascular aortic repair. J Vasc Surg. 2014 ; 60 : 1481-90.
PubMed
14) Keith CJ Jr, Passman MA, Carignan MJ, et al. Protocol implementation of selective postoperative lumbar spinal drainage after thoracic aortic endograft. J Vasc Surg. 2012 ; 55 : 1-9.
PubMed
15) Wynn MM, Sebranek J, Marks E, et al. Complications of spinal fluid drainage in thoracic and thoracoabdominal aortic aneurysm surgery in 724 patients treated from 1987 to 2013. J Cardiothorac Vasc Anesth. 2015 ; 29 : 342-50.
PubMed
16) Olson DM, Atem F, Busch DR. Evaluation of a new catheter for simultaneous intracranial pressure monitoring and cerebral spinal fluid drainage : a pilot study. Neurocrit Care. 2019 ; 31 : 225-6.
PubMed
17) Tshomba Y, Leopardi M, Mascia D, et al. Automated pressure-controlled cerebrospinal fluid drainage during open thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2017 ; 66 : 37-44.
PubMed
18) Harky A, Fok M, Fraser H, et al. Could cerebrospinal fluid biomarkers offer better predictive value for spinal cord ischaemia than current neuromonitoring techniques during thoracoabdominal aortic aneurysm repair-a systematic review. Braz J Cardiovasc Surg. 2019 ; 34 : 464-71.
PubMed

術中管理

P.154 掲載の参考文献
1) Pearse RM, Harrison DA, MacDonald N, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery : a randomized clinical trial and systematic review. JAMA. 2014 ; 311 : 2181-90.
PubMed
2) Som A, Maitra S, Bhattacharjee S, et al. Goal directed fluid therapy decreases postoperative morbidity but not mortality in major non-cardiac surgery : a meta-analysis and trial sequential analysis of randomized controlled trials. J Anesth. 2017 ; 31 : 66-81.
 
3) Gomez-Izquierdo JC, Trainito A, Mirzakandov D, et al. Goal-directed fluid therapy does not reduce primary postoperative ileus after elective laparoscopic colorectal surgery : a randomized controlled trial. Anesthesiology. 2017 ; 127 : 36-49.
 
4) Makaryus R, Miller TE, Gan TJ. Current concepts of fluid management in enhanced recovery pathways. Br J Anaesth. 2018 ; 120 : 376-83.
PubMed
5) Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass : a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012 ; 144 : 223-30.
PubMed
6) Bayer O, Schwarzkopf D, Doenst T, et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis. Crit Care Med. 2013 ; 41 : 2532-42.
PubMed
7) Ryhammer PK, Tang M, Hoffmann-Petersen J, et al. Colloids in cardiac surgery-friend or foe? J Cardiothorac Vasc Anesth. 2017 ; 31 : 1639-48.
PubMed
8) Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995 ; 130 : 423-9.
PubMed
9) Polonen P, Ruokonen E, Hippelainen M, et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000 ; 90 : 1052-9.
PubMed
10) McKendry M, McGloin H, Saberi D, et al. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ. 2004 ; 329 : 258.
PubMed
11) Kapoor PM, Kakani M, Chowdhury U, et al. Early goal-directed therapy in moderate to high-risk cardiac surgery patients. Ann Card Anaesth. 2008 ; 11 : 27-34.
PubMed
12) Smetkin AA, Kirov MY, Kuzkov VV, et al. Single transpulmonary thermodilution and continuous monitoring of central venous oxygen saturation during off-pump coronary surgery. Acta Anaesthesiol Scand. 2009 ; 53 : 505-14.
PubMed
13) Giglio M, Dalfino L, Puntillo F, et al. Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2012 ; 15 : 878-87.
PubMed
14) Aya HD, Cecconi M, Hamilton M, et al. Goal-directed therapy in cardiac surgery : a systematic review and meta-analysis. Br J Anaesth. 2013 ; 110 : 510-7.
PubMed
15) Osawa EA, Rhodes A, Landoni G, et al. Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery : a randomized clinical trial and systematic review. Crit Care Med. 2016 ; 44 : 724-33.
 
16) Goepfert MS, Richter HP, Zu Eulenburg C, et al. Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit : a prospective, randomized controlled trial. Anesthesiology. 2013 ; 119 : 824-36.
PubMed
17) Johnston LE, Thiele RH, Hawkins RB, et al. Goal-directed resuscitation following cardiac surgery reduces acute kidney injury : a quality initiative prepost analysis. J Thorac Cardiovasc Surg. 2020 ; 159 : 1868-77.
PubMed
18) Deschamps A, Hall R, Grocott H, et al. Cerebral oximetry monitoring to maintain normal cerebral oxygen saturation during high-risk cardiac surgery : a randomized controlled feasibility trial. Anesthesiology. 2016 ; 124 : 826-36.
PubMed
P.160 掲載の参考文献
1) Goel R, Patel EU, Cushing MM, et al. Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry. JAMA Surg. 2018 ; 153 : 826-33.
 
2) Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016 ; 10 (10) : CD002042.
PubMed
3) Barker SJ, Shander A, Ramsay MA. Continuous noninvasive hemoglobin monitoring : a measured response to a critical review. Anesth Analg. 2016 ; 122 : 565-72.
PubMed
4) Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB : red blood cell transfusion thresholds and storage. JAMA. 2016 ; 316 : 2025-35.
PubMed
5) Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017 ; 377 : 2133-44.
 
6) Shehata N, Mistry N, da Costa BR, et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery : a meta-analysis. Eur Heart J. 2019 ; 40 : 1081-8.
PubMed
7) Cho BC, DeMario VM, Grant MC, et al. Discharge hemoglobin level and 30-day readmission rates after coronary artery bypass surgery. Anesth Analg. 2019 ; 128 : 342-48.
PubMed
8) Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study : comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013 ; 148 : 127-36.
PubMed
9) Delaney M, Stark PC, Suh M, et al. Massive transfusion in cardiac surgery : the impact of blood component ratios on clinical outcomes and survival. Anesth Analg. 2017 : 124 ; 1777-82.
PubMed
10) Tsukinaga A, Maeda T, Takaki S, et al. Relationship between fresh frozen plasma to packed red blood cell transfusion ratio and mortality in cardiovascular surgery. J Anesth. 2018 : 32 : 539-46.
PubMed
11) Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012 ; 52 Suppl 1 : 65S-79S.
 
12) Desborough M, Sandu R, Brunskill SJ, et al. Fresh frozen plasma for cardiovascular surgery. Cochrane Database Syst Rev. 2015 ; (7) : CD007614.
PubMed
13) Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients : prevalence, incidence, and risk factors. Crit Care Med. 2005 ; 33 : 1565-71.
PubMed

術後管理

P.169 掲載の参考文献
1) Suzuki S, Mihara Y, Hikasa Y, et al. Current ventilator and oxygen management during general anesthesia : a multicenter, cross-sectional observational study. Anesthesiology. 2018 ; 129 : 67-76.
PubMed
2) Suzuki S, Eastwood GM, Peck L, et al. Current oxygen management in mechanically ventilated patients : a prospective observational cohort study. J Crit Care. 2013 ; 28 : 647-54.
PubMed
3) Young RW. Hyperoxia : a review of the risks and benefits in adult cardiac surgery. J Extra Corpor Technol. 2012 ; 44 : 241-9.
PubMed
4) Haque WA, Boehmer J, Clemson BS, et al. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol. 1996 ; 27 : 353-7.
PubMed
5) Mak S, Azevedo ER, Liu PP, et al. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest. 2001 ; 120 : 467-73.
PubMed
6) McNulty PH, Robertson BJ, Tulli MA, et al. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol (1985). 2007 ; 102 : 2040-5.
PubMed
7) Stub D, Smith K, Bernard S, et al. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study). Am Heart J. 2012 ; 163 : 339-45 e1.
 
8) Ni YN, Wang YM, Liang BM, et al. The effect of hyperoxia on mortality in critically ill patients : a systematic review and meta analysis. BMC Pulm Med. 2019 ; 19 : 53.
 
9) Neumar RW, Shuster M, Callaway CW, et al. Part 1 : executive summary : 2015 American Heart Association Guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015 ; 132 (18 Suppl 2) : S315-67.
 
10) Sutton AD, Bailey M, Bellomo R, et al. The association between early arterial oxygenation in the ICU and mortality following cardiac surgery. Anaesth Intensive Care. 2014 ; 42 : 730-5.
PubMed
11) Eastwood GM, Chan MJ, Peck L, et al. Conservative versus conventional oxygen therapy for cardiac surgical patients : a before-and-after study. Anaesth Intensive Care. 2019 ; 47 : 175-82.
PubMed
12) ICU-ROX Investigators, the Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Conservative oxygen therapy during mechanical ventilation in the ICU. N Engl J Med. 2020 ; 382 : 989-98.
 
13) Wong WT, Lai VK, Chee YE, et al. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2016 ; 9 (9) : CD003587.
PubMed
14) Kiessling AH, Huneke P, Reyher C, et al. Risk factor analysis for fast track protocol failure. J Cardiothorac Surg. 2013 ; 8 : 47.
PubMed
15) Greco M, Landoni G, Biondi-Zoccai G, et al. Remifentanil in cardiac surgery : a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2012 ; 26 : 110-6.
PubMed
16) Engelman DT, Ben Ali W, Williams JB, et al. Guidelines for perioperative care in cardiac surgery : Enhanced Recovery After Surgery Society recommendations. JAMA Surg. 2019 ; 154 : 755-66.
PubMed
17) Ender J, Borger MA, Scholz M, et al. Cardiac surgery fast-track treatment in a postanesthetic care unit : six-month results of the Leipzig fast-track concept. Anesthesiology. 2008 ; 109 : 61-6.
 
18) Guinot PG, Spitz A, Berthoud V, et al. Effect of opioid-free anaesthesia on post-operative period in cardiac surgery : a retrospective matched case-control study. BMC anesthesiology. 2019 ; 19 : 136.
 
P.177 掲載の参考文献
1) Segal N, Bonifacio AS, Schroeder A, et al. Can we make postoperative patient handovers safer? A systematic review of the literature. Anesth Analg. 2012 ; 115 : 102-15.
 
2) Hall M, Robertson J, Merkel M, et al. A structured transfer of care process reduces perioperative complications in cardiac surgery patients. Anesth Analg. 2017 ; 125 : 477-82.
 
3) 讃井將満. 簡単アンケート第51弾. 心臓血管外科術後管理 (2016年3月実施). JSEPTIC 臨床研究委員会. http://www.jseptic.com/rinsho/questionnaire_51.pdf (2020年6月30日閲覧)
 
4) Benoit MA, Bagshaw SM, Norris CM, et al. Postoperative complications and outcomes associated with a transition to 24/7 intensivist management of cardiac surgery patients. Crit Care Med. 2017 ; 45 : 993-1000.
PubMed
5) Slight RD, Bappu NJ, Nzewi OC, et al. Perioperative red cell, plasma, and blood volume change in patients undergoing cardiac surgery. Transfusion. 2006 ; 46 : 392-7.
PubMed
6) St Andre AC, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med. 2005 ; 33 : 2082-93.
PubMed
7) Marik PE, Cavallazzi R, Vasu T, et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients : a systematic review of the literature. Crit Care Med. 2008 : 37 : 2642-7.
 
8) Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness : a systematic review and meta-analysis. Intensive Care Med. 2016 ; 42 : 1935-47.
PubMed
9) Piccioni F, Bernasconi F, Tramontano GTA, et al. A systematic review of pulse pressure variation and stroke volume variation to predict fluid responsiveness during cardiac and thoracic surgery. J Clin Monit Comput. 2017 ; 31 : 677-84.
PubMed
10) Garcia MI, Romero MG, Cano AG, et al. Dynamic arterial elastance as a predictor of arterial pressure response to fluid administration : a validation study. Crit Care. 2014 ; 18 : 626.
PubMed
11) Bar S, Leviel F, Abou Arab O, et al. Dynamic arterial elastance measured by uncalibrated pulse contour analysis predicts arterial-pressure response to a decrease in norepinephrine. Br J Anaesth. 2018 ; 121 : 534-40.
PubMed
12) 小山薫. 静脈血酸素飽和度をみる. 日臨麻会誌. 2015 ; 35 : 487-91.
Medical*Online
13) Headley JM. Strategies to optimize the cardiorespiratory status of the critically ill. AACN Clin Issues. 1995 ; 6 : 121-34.
PubMed
14) Joshi R, de Witt B, Mosier JM. Optimizing oxygen delivery in the critically ill : the utility of lactate and central venous oxygen saturation (ScvO2) as a road-map of resuscitation in shock. J Emerg Med. 2014 ; 47 : 493-500.
 
15) Wittayachamnankul B, Chentanakij B, Sruamsiri K, et al. The role of central venous oxygen saturation, blood lactate, and centralvenous-to-arterial carbon dioxide partial pressure difference as a goal and prognosis of sepsis treatment. J Crit Care. 2016 ; 36 : 223-9.
 
16) Dunning J, Fabbri A, Kolh PH, et al. Guideline for resuscitation in cardiac arrest after cardiac surgery. Eur J Cardiothorac Surg. 2009 ; 36 : 3-28.
PubMed
17) Ngaage DL, Cowen ME. Survival of cardiorespiratory arrest after coronary artery bypass grafting or aortic valve surgery. Ann Thorac Surg. 2009 ; 88 : 64-8.
 
18) Lavonas EJ, Drennann IR, Gabrielli A, et al. Part 10 : special circumstances of resuscitation : 2015 AHA guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015 ; 132 (18 Suppl 2) : S501-18.
 

エキスパートオピニオン 私ならこうする心臓血管管理

P.184 掲載の参考文献
1) Sasaki H, Ogino H, Matsuda H, et al. Integrated total arch replacement using selective cerebral perfusion : a 6-year experience. Ann Thorac Surg. 2007 ; 83 : S805-10.
PubMed
P.189 掲載の参考文献
1) Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery : trends over 20 years. Ann Thorac Surg. 2011 ; 92 : 1678-84.
PubMed
2) Ding W, Ji Q, Shi Y, et al. Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting. Int Heart J. 2015 ; 56 : 144-9.
PubMed
3) Royster RL. Myocardial dysfunction following cardiopulmonary bypass : recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration. J Cardiothorac Vasc Anesth. 1993 ; 7 : 19-25.
 
4) Ginwalla M, Tofovic DS. Current status of inotropes in heart failure. Heart Fail Clin. 2018 ; 14 : 601-16.
PubMed
5) Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications : an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005 ; 46 : 57-64.
 
6) Carrel T, Englberger L, Mohacsi P, et al. Low systemic vascular resistance after cardiopulmonary bypass : incidence, etiology, and clinical importance. J Card Surg. 2000 ; 15 : 347-53.
PubMed
7) Sun X, Zhang L, Hill PC, et al. Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery? Eur J Cardiothorac Surg. 2008 ; 34 : 820-5.
PubMed
P.196 掲載の参考文献
1) エホバの証人公式ウェブサイト. 世界各地のエホバの証人. https://www.jw.org/ja/ (2020年7月1日閲覧)
 
2) Hughes DB, Ullery BW, Barie PS. The contemporary approach to the care of Jehovah's Witnesses. J Trauma. 2008 ; 65 : 237-47.
 
3) Carson JL, Noveck H, Berlin JA, et al. Mortality and morbidity in patients who very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002 : 42 : 812-8.
PubMed
4) Ott DA, Cooley DA. Cardiovascular surgery in Jehovah's Witnesses : report of 542 operations without blood transfusion. JAMA. 1977 : 238 : 1256-8.
PubMed
5) Vaislic CD, Dalibon N, Ponzio O, et al. Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients : 21 years experience. J Cardiothorac Surg. 2012 : 7 : 95.
PubMed
6) Tanaka A, Ota T, Uriel N, et al. Cardiovascular surgery in Jehovah's Witness patients : the role of preoperative optimization. J Thorac Cardiovasc Surg. 2015 : 150 : 976-83.
 
7) Kitchen CS. Are transfusions overrated? Surgical outcome of Jehovah's Witnesses. Am J Med. 1993 : 94 : 117-9.
 

書評

最近チェックした商品履歴

Loading...